➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Colorcon
Medtronic
Moodys
McKesson

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DISULFIRAM

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Disulfiram

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000278 ↗ Disulfiram for Cocaine-Alcohol Abuse - 3 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-09-01 The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
NCT00000278 ↗ Disulfiram for Cocaine-Alcohol Abuse - 3 Completed VA Connecticut Healthcare System Phase 2 1994-09-01 The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
NCT00000278 ↗ Disulfiram for Cocaine-Alcohol Abuse - 3 Completed Yale University Phase 2 1994-09-01 The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
NCT00002065 ↗ Depot Disulfiram for AIDS and ARC Completed St. Vincent's Medical Center N/A 1969-12-31 To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.
NCT00094289 ↗ Interactions Between Cocaine and Ethanol and Disulfiram - 1 Unknown status National Institute on Drug Abuse (NIDA) Phase 1 2004-08-01 The purpose of this study is to assess potential interactions between intravenous cocaine and ethanol and oral disulfiram.
NCT00142844 ↗ Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1999-09-01 Many cocaine dependent individuals are also dependent on alcohol. Such individuals respond poorly to existing treatments and have received little research attention in the past. The purpose of this study is to determine whether the combination of naltrexone and disulfiram is useful in decreasing alcohol use and cravings in people diagnosed with both cocaine and alcohol dependence.
NCT00142844 ↗ Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 Completed University of Pennsylvania Phase 2 1999-09-01 Many cocaine dependent individuals are also dependent on alcohol. Such individuals respond poorly to existing treatments and have received little research attention in the past. The purpose of this study is to determine whether the combination of naltrexone and disulfiram is useful in decreasing alcohol use and cravings in people diagnosed with both cocaine and alcohol dependence.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Disulfiram

Condition Name

Condition Name for Disulfiram
Intervention Trials
Alcohol Dependence 6
Cocaine-Related Disorders 4
Alcoholism 4
Glioblastoma 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Disulfiram
Intervention Trials
Alcoholism 16
Cocaine-Related Disorders 11
Glioblastoma 7
Disease 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Disulfiram

Trials by Country

Trials by Country for Disulfiram
Location Trials
United States 47
Canada 2
Brazil 2
Australia 2
Slovakia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Disulfiram
Location Trials
California 9
Connecticut 6
Pennsylvania 4
New York 4
Missouri 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Disulfiram

Clinical Trial Phase

Clinical Trial Phase for Disulfiram
Clinical Trial Phase Trials
Phase 4 9
Phase 3 1
Phase 2/Phase 3 3
[disabled in preview] 43
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Disulfiram
Clinical Trial Phase Trials
Completed 30
Not yet recruiting 13
Recruiting 12
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Disulfiram

Sponsor Name

Sponsor Name for Disulfiram
Sponsor Trials
National Institute on Drug Abuse (NIDA) 10
Yale University 8
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 7
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Disulfiram
Sponsor Trials
Other 87
NIH 19
Industry 7
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Dow
McKesson
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.